On May 24 and 25, Dubai will play host to healthcare innovation leaders at the inaugural EMERGE GHI event to be held at the Conrad Dubai.
The event connects the most innovative ideas in healthcare with the best minds in business and investment, connecting investors with a global community of health-tech innovators looking to move their companies to the next stage of their entrepreneur journey. The event also offers healthcare providers and other stakeholders a clear window to the next-generation technologies that are re-shaping the industry.
EMERGE GHI runs alongside the PrecisionMed Exhibition & Summit, the Middle East’s first event dedicated to precision medicine. The two-day think tank, identified as an important driver in the GCC’s burgeoning healthcare industry, will move beyond the existing medical ecosystem in search of new frontiers.
“EMERGE GHI convenes the biggest international community of health tech-disruptors and finance partners ever assembled for a dedicated conference like this in the region, while delivering momentum to official efforts aimed at fostering the Middle East’s reputation as a centre of innovation and opportunity,” said event director David Stradling. “Participants will experience first-hand the vast commitment countries like UAE and Saudi Arabia have to the health-tech start-up market, and meet decision-makers who are sanctioning millions of dollars in government backing for research and development across the sector.”
From precision medicine to digital diagnostics, artificial intelligence and biocomputing, technology is fostering much-needed change to the health ecosystem. In tracking such emerging global trends in this fast-moving environment, EMERGE GHI will bring together over 100 health-tech startups and 50 life science investors.
“There’s never been a moment like this in human history. Yes, we’re living in uncertain times, but, on the other hand, our average life expectancy is at an all-time high, extreme poverty is at an all-time low and humanity has never been this productive. We’re making technological advances our ancestors didn’t dream of, by pushing the boundaries of our understanding of the world around us. The pandemic has paved the way for the wider adoption of virtual care and remote patient monitoring platforms. It’s an exciting time to be part of this transformational journey.” says Edward Kliphuis, partner at leading European VC firm Sofinnova Partners and a member of the EMERGE advisory board.
Lee Shapiro, managing partner of 7wire Ventures and also on the EMERGE GHI board, adds: “There are some incredible scientific discoveries and advances happening right now. And the convergence of these breakthrough technologies is enabling adoption in practice with unprecedented speed. We’re lucky enough to have the opportunity to address the challenges that stand in the way of so many of us in achieving good health as cutting-edge technologies that are available in other areas of our lives are now making their way into healthcare.”
The programme includes 50 confirmed speakers, most of whom are speaking for the first time in the Middle East, and three keynote addresses from industry trailblazers.
Jalil Allabadi, managing partner of the Middle East digital health platform Altibbi, will focus on the way forward for healthcare, given the problems that the world still needs to solve. He founded Altibbi with his father Dr Abdel Aziz in 2008 in Jordan, which gives families in the MENA region access to qualified doctors via online services, presenting reliable, up-to-date and simplified medical information in Arabic.
Also on the agenda is Glen Tullman, CEO of consumer-directed health and care platform Transcarent. Based in Chicago, Tullman was the founder and most recently executive chairman of Livongo, which became the largest consumer digital health initial public offering in history on listing in July 2019, and offers a wealth of experience for growing startups.
Delegates will also have the opportunity to listen to Eddie Martucci, co-founder & CEO of Boston-based Akili Interactive, which has developed the first and only prescription treatment delivered through a video game, which is now FDA approved.
According to market research firm Dealroom, global venture capital funding in healthtech and biotech is at record high, with several fundamental shifts taking place in healthcare, providing tailwinds for market disruptors.
Globally, venture capital investment in health-tech and biotech startups has smashed previous records, attracting a respective $45 billion and $34 billion in 2021. The three highest quarters for health-tech and biotech investment ever were in 2021, with a record number of new unicorns (startup companies valued at over $1 billion) announced last year.
Following an unprecedented year for biotech in 2021, Dealroom adds that investment figures have remained resilient after a pandemic-driven surge and, while the US retains its global lead, increasing growth is expected in new markets, notably the Middle East and Asia.
Sophie Smith, CEO of femtech platform Nabta Health and also on the EMERGE advisory board, concluded: “There are some fabulous opportunities across all sectors to build businesses that will make a huge impact. This is driven mainly by the region’s youthful and still growing populations and their ever-increasing desire to build companies destined to become global players.”
Press Release Received over Mail. International Business Magazine is the media partner to Emerge GHI
